Andrianarivelo M R, Rabarijaona L, Boisier P, Chezzi C, Zeller H G
Virology Unit, Institut Pasteur, Antananarivo, Madagascar.
Trop Med Int Health. 1999 Jan;4(1):50-7. doi: 10.1046/j.1365-3156.1999.00350.x.
From July 1995 to December 1996, 3185 stool specimens from healthy children aged 6-59 months attending 6 dispensaries in the Antananarivo area were examined for poliovirus. The children had been routinely immunized according to the Expanded Programme on Immunization (EPI) schedule and received the last dose of oral polio vaccine (OPV) more than 1 month before stool collection. 99.4% of the children were immunized with at least 3 doses of OPV. HEp-2 cell culture revealed virus infections in 192 stools (6.0%), including 9 poliovirus (0.3%) and 183 nonpolio enterovirus isolates (5.7%). Infections occurred throughout the year, but incidence was higher during the hot and rainy season (P=0.01). Using a neutralization test with monoclonal antibodies and PCR-RFLP in two genomic regions coding for the VP1 capsid and RNA polymerase, 4 wild polioviruses (3 type 1 and 1 type 3) and 5 vaccine-related polioviruses (2 Sabin 1-like variants, 1 Sabin 2-like and 2 Sabin 3-like) strains were identified. The wild polioviruses were isolated at the beginning and the end of the dry season. Similar RFLP patterns were observed for the 3 wild type 1 polioviruses. Comparison of partial genomic sequences in the VP1/2 A region of 1 of the wild type 1 isolates with 2 wild type strains isolated in Antananarivo in 1992 and 1993 showed a divergence of at least 10% between the strains, suggesting at least two different pathways of transmission during this period. Our findings demonstrate that immunization with 3 doses of OPV did not prevent intestinal carriage of wild poliovirus strains, and that there is a risk of wild poliovirus transmission to susceptible children in the area. Multiple strategies are required to improve immunization coverage in Madagascar.
1995年7月至1996年12月,对塔那那利佛地区6家诊疗所6至59个月大的健康儿童的3185份粪便标本进行了脊髓灰质炎病毒检测。这些儿童已按照扩大免疫规划(EPI)的时间表进行了常规免疫,并且在粪便采集前1个月以上接受了最后一剂口服脊髓灰质炎疫苗(OPV)。99.4%的儿童接种了至少3剂OPV。HEp-2细胞培养显示192份粪便(6.0%)存在病毒感染,其中包括9份脊髓灰质炎病毒(0.3%)和183份非脊髓灰质炎肠道病毒分离株(5.7%)。感染全年都有发生,但在炎热多雨季节发病率更高(P=0.01)。通过使用针对编码VP1衣壳和RNA聚合酶的两个基因组区域的单克隆抗体中和试验和PCR-RFLP,鉴定出4株野生脊髓灰质炎病毒(3株1型和1株3型)和5株疫苗相关脊髓灰质炎病毒(2株Sabin 1样变异株、1株Sabin 2样和2株Sabin 3样)毒株。野生脊髓灰质炎病毒在旱季开始和结束时被分离出来。3株野生1型脊髓灰质炎病毒观察到相似的RFLP模式。将1株野生1型分离株VP1/2A区域的部分基因组序列与1992年和1993年在塔那那利佛分离的2株野生型毒株进行比较,发现这些毒株之间的差异至少为10%,这表明在此期间至少存在两条不同的传播途径。我们的研究结果表明,接种3剂OPV并不能预防野生脊髓灰质炎病毒株在肠道内的携带,并且该地区存在野生脊髓灰质炎病毒传播给易感儿童的风险。需要采取多种策略来提高马达加斯加的免疫覆盖率。